PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE [PD 115934] IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA.

Trial Profile

PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE [PD 115934] IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Aug 2012

At a glance

  • Drugs PD 115934 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Mar 2012 Actual patient number (20) added as reported by ClinicalTrials.gov.
    • 12 Mar 2012 Actual end date (February 2008) added as reported by ClinicalTrials.gov.
    • 16 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top